New paradigms in neuroendocrinology: Relationships between obesity, systemic inflammation and the neuroendocrine system

Journal of Endocrinological Investigation

Volumn 27, Issue 2, 2004, Pages 182-186

  Toni, Roberto ^a,d,e   Malaguti, A ^a   Castorina, S ^b   Roti, E ^c   Lechan, R M ^d  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MAGGIORE HOSPITAL   (Italy)

Author keywords

Cytokines; Inflammation; Neuroendocrine system; Obesity; Visceral fat

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; BODY FAT; BODY MASS; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID STORAGE; NEUROENDOCRINOLOGY; OBESITY; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; VIRUS INFECTION;

EID: 1942520404     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346266     Document Type: Review

References (37)

1. Medvei VC. The history of clinical endocrinology. Parthenon Publishing 1993, 7-8.
2. Braddon FE, Rodgers B, Wadsworth ME, Davies JM. Onset of obesity in a 36 year birth cohort study. BMJ 1986, 293: 299-303.
3. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998, 97: 2099-100.
4. Vallance P, Collier J, Bhagat K. Infection, inflammation and infarction: does acute endothelial dysfunction provide a link? Lancet 1997, 349: 1391-2.
5. Das UN. Is obesity an inflammatory condition? Nutrition 2001, 17: 953-56,
6. Balagopal P, Sweeten S, Mauras N. Increased synthesis of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol Endocrinol Metab 2002, 282: E899-904.
7. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280: E745-51.
8. Harris TB, Ferrucci L, Tracy RP, et al. Association of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999, 106: 506-12.
9. Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000, 102: 3060-7.
10. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot differences and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83: 847-50.
11. Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue in obese women after weight loss. J Clin Endocrinol Metab 2000, 85: 3338-42.
12. Aubert J, Darimont C, Safonova I, Ailhaud G, Negrel R. Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem J 1997, 328: 701-6.
13. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001, 60: 329-39.
14. Umemura S, Nyui N, Tamura K, et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997, 10: 629-33.
15. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998, 12: 57-65.
16. Faggioni R, Fantuzzi G, Gabay C, et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999, 276: R136-42.
17. Jequier E. Leptin signalling, adiposity and energy balance. Ann NY Acad Sci 2002, 967: 379-88.
18. Weyer C, Funahashi R, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930-5.
19. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin 6 the link? Atherosclerosis 2000, 148: 209-14.
20. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995, 332: 1351-62.
21. Halleux CM, Servais I, Reul BA, Detry R, Brichard SM. Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increaed responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab 1998, 83: 902-10.
22. Bartolome J, Huguenard J, Slotkin TA. Role of ornithine decarboxilase in cardiac growth and hypertrophy. Science 1980, 210: 793-4.
23. Straub RH, Westemann J, Scholmerich J, Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today 1998, 19: 409-13.
24. Boicelli CA, Baldassarri AM, Bondi A, Giuliani AM, Toni R. Towards NMR spectroscopy in vivo: II. Relationship between NMR parameters and histology. In: Bradbury EM, Nicolini C eds. NMR in the life sciences. NATO ASI Series. New York: Plenum Press, Series A: Life Sciences. 1987, 179-85.
25. Toni R, Boicelli CA, Baldassarri AM. Characterization of human pathological papillary muscles by 1H-NMR spectroscopic and histologic analysis. Int J Cardiol 1986, 11: 231-4.
26. Madden KS, Felten DL. Experimental basis for neural-immune interactions. Physiol Rev 1995, 75: 77-106.
27. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993, 329: 1246-53.
28. Giorgino R. Pathophysiology of the sympathoadrenal system. J Endocrinol Invest 1988, 11: 817-29.
29. van Grool J, van Vugt H, Helle M, Aarden LA. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol 1990, 57: 200-10.
30. Papanicolaou DA, Petrides JS, Tsigos C, et al. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996, 271: E601-5.
31. Dhurandhar NV, Atkinson RL. Viruses and obesity. Curr Opin Endocrinol Diabet 2000, 7: 247-51.
32. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL. Screening of human sera for antibody against avian adenovirus. Obes Res 1997, 5: 464-69.
33. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum?". Lancet 1997, 349: 1210-3.
34. Dhurandhar NV. Infections and body weigth: an emerging relationship? Int J Obes 2002, 26: 745-6.
35. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391: 82-6.
36. Yang WS, Jeng CY, Tj Wu, et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002, 25: 376-80.
37. Lechan RM, Toni R. Thyroid hormones in neural tissue. In: Pfaff D, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT eds. Hormones, brain and behavior. San Diego: Academic Press. 2002, 157-238.